MedPath

Comparing the Effects of Mycozin and Clotrimazole on Vaginal Candidiasis

Phase 3
Conditions
Vaginal Candidiasis.
Candidiasis of vulva and vagina
B37.3
Registration Number
IRCT20120718010324N77
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
126
Inclusion Criteria

Age 18-45 years
married
Being literate in reading and writing
Lack of allergy to herbal medicines
Suffering from candidal vaginitis

Exclusion Criteria

Suffering from chronic diseases such as diabetes, AIDS, immune system disorders, depression, etc. currently, according to the participant's statement
Taking antibiotics and corticosteroids during the last two weeks according to the participant's statement
Menstruation at the time of study
Current use of oral contraceptives as reported by the participant
The presence of a wound or mass in the cervix when viewed with a speculum
Existence of severe mental stress during the last three months, such as the death of first-degree relatives
Presence of pregnancy or breastfeeding at the time of study
Taking other drugs to treat vaginitis
Having recurrent vulvovaginitis (more than four times per year)
Abnormal uterine bleeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath